Amber Bio is entering the race to edit large blocks of genetic material with a multi-kilobase editing platform for RNA writing. The technology represents a sweeping form of search-and-replace editing for mRNA.
Amber Bio launches with $26 million in seed funding to develop an RNA-editing platform. The platform is designed to rewrite thousands of bases on a single strand in one pass, aiming to treat diseases with diverse mutations.
Aug 2023 · Chemical & Engineering NewsNews article
Amber Bio launches with $26 million in seed financing to develop an RNA editing platform for previously undruggable diseases. The company’s platform uses multi-kilobase edits and is described as first-of-its-kind; Playground Global and Andreessen Horowitz co-led the financing.
San Francisco-based Amber Bio launches a multi-kilobase RNA-editing platform, backed by a $26 million seed round. Playground Global and Andreessen Horowitz Bio + Health co-led the financing.
Aug 2023 · GEN - Genetic Engineering and Biotechnology NewsNews article
